Neutrophil extracellular traps (NETs) are increasingly recognized as key mediators in the development of venous thromboembolism (VTE). Animal models and in vitro studies showed that NETs form a ...
COVID-19 patients who suffer life-threatening complications such as blood clots and inflammation also experience dysregulated NETosis. NETosis is a cell death process that generates neutrophil ...
MILAN, Italy, February 1, 2023 - The Discovery Biology Unit at Dompé farmaceutici, in collaboration with Università degli Studi dell’Aquila, has published in December on Frontiers in Oncology a review ...
HENDERSON, Nev., Feb. 6, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) Volition a multi-national epigenetics company, announces its first commercial sale of Volition's High Throughput ...
While the majority of infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will recover, a significant minority progress to severe or fatal coronavirus disease 2019 ...
OSS, Netherlands--(BUSINESS WIRE)--http://www.citryll.com/ announced today the first closing of a targeted € 15 million investment round, funded by ModiQuest B.V ...
Myofibroblasts are the primary effector cells in tissue remodeling and fibrosis. 2 They are believed to originate from mesenchymal-derived cells and pericytes (contractile cells that envelop the ...
Volitionrx Ltd. won the CE mark for its Nu.Q NETs test for the detection, evaluation and management of NETosis, a type of cell death characterized by the release of neutrophil extracellular traps, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results